Evidence map›Paper›PMID 41017038›Full record

ArticleEmerging infectious diseases2025

Spotted Fever Group Rickettsioses among Hospitalized Patients and Circulation of Rickettsia in Ticks, Kazakhstan, 2019.

Yekaterina V Bumburidi, Dmitriy V Berezovskiy, Bakhytkul T Zhakipbayeva, Roberta Z Horth, Alexander J Millman, William L Nicholson, Galina E Zemtsova, Victoria Seffren, Elina R Maltseva, Zhanna A Berdygulova and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yekaterina V Bumburidi
Dmitriy V Berezovskiy
Bakhytkul T Zhakipbayeva
Roberta Z Horth
Alexander J Millman
William L Nicholson
Galina E Zemtsova
Victoria Seffren
Elina R Maltseva
Zhanna A Berdygulova
Yekaterina O Ostapchuk
Yuliya V Perfilyeva
Andrey M Dmitrovskiy
Zhansulu K Dukayeva
Zhanna Zh Shapiyeva

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testing for spotted fever group rickettsioses (SFGR) and the criteria for identifying suspected patients are not routinely used in Kazakhstan. In 2019, we performed a cross-sectional study in 6 sentinel hospitals in the Pavlodar region. We tested 105 hospitalized patients with SFGR-like symptoms by using PCR or indirect immunofluorescence antibody assay and identified 62 cases of SFGR. Most (78%) cases of disease were caused by Rickettsia sibirica and R. raoultii. Cutaneous signs (eschar or rash) were found in 87% of SFGR patients; 79% had a rash, 48% had an eschar, and 13% had neither. Testing of suspected rickettsia cases resulted in a 27% increase in laboratory-detected SFGR over the mean of the previous 3 years (62 vs. 49). Broadening the case definition by including fever, headache, or myalgia and expanding routine testing for suspected cases of SFGR could contribute to improved case detection and earlier treatment.

Indexed as

RickettsiaSpotted Fever Group RickettsiosisTicksAdolescentAdultAgedAnimalsChildCross-Sectional StudiesFemaleHospitalizationHumansKazakhstanMaleMiddle AgedYoung AdultbacteriaKazakhstanRickettsia raoultiiRickettsia sibiricaRickettsia slovacarickettsiosesSpotted fever group rickettsiaSpotted fever group rickettsiosesvector-borne infectionszoonoses

Identifiers

PMID41017038
PMCPMC12483003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.